Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin and Metformin for NAFLD in T2DM
NCT05480007Completed
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jan 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of sitagliptin in non-alcoholic fatty liver disease (NAFLD) (4 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Intrahepatic Lipid at 24 weeks. Started Jan 2011; status: completed.
02
Drugs
sitagliptin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT05480007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480007.